Pre-HITV Consulting Service

Dendritic cell therapy is one of the regenerative medical methods, and its mechanism is to identify tumor antigens by dendritic cells obtained in vitro, training these dendritic cells to recognize these antigens, and then introducing the trained dendritic cells into the patient's body to resist (cancer cells), while the activation of dendritic cells is achieved through cancer vaccines.  

Target population:Patients who have completed cancer radiotherapy and chemotherapy.

Treatment process:

1. First, collect 30ml of blood, and culture and activate dendritic cells and lymphocytes in a sterile room.

2. The cultured dendritic cells along with immune adjuvants are injected into the patient’s body through the descending artery under CT monitoring.

3. Inject lymphocytes intravenously 24-72 hours later.

Treatment cycle: once a year.

Note: The price when placing an order is only forservice deposit.